Your browser doesn't support javascript.
loading
Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation.
Repici, M; Centeno, C; Tomasi, S; Forloni, G; Bonny, C; Vercelli, A; Borsello, T.
Afiliación
  • Repici M; Département de Biologie Cellulaire et de Morphologie, Université de Lausanne, rue du Bugnon 9, Lausanne CH-1005, Switzerland.
Neuroscience ; 150(1): 40-9, 2007 Nov 30.
Article en En | MEDLINE | ID: mdl-17900813
The c-Jun N-terminal kinase (JNK) signaling pathway plays a critical role in ischemic brain injury. The d-retro-inverso form of c-Jun N-terminal kinase-inhibitor (D-JNKI1), a cell-permeable inhibitor of JNK, powerfully reduces neuronal death induced by permanent and transient ischemia, even when administered 6 h after the ischemic insult, offering a clinically relevant window. We investigated the JNK molecular cascade activation in rat cerebral ischemia and the effects of D-JNKI1 on this cascade. c-Jun activation starts after 3 h after ischemia and peaks at 6 h in the ischemic core and in the penumbra at 1 h and at 6 h respectively. The 6 h c-Jun activation peak correlates well with that of P-JNK. We also examined the activation of the two direct JNK activators, MAP kinase kinase 4 (MKK4) and MAP kinase kinase 7 (MKK7). MKK4 showed the same time course as JNK in both core and penumbra, reaching peak activation at 6 h. MKK7 did not show any significant increase of phosphorylation in either core or penumbra. D-JNKI1 markedly prevented the increase of P-c-Jun in both core and penumbra and powerfully inhibited caspase-3 activation in the core. These results confirm that targeting the JNK cascade using the TAT cell-penetrating peptide offers a promising therapeutic approach for ischemia, raising hopes for human neuroprotection, and elucidates the molecular pathways leading to and following JNK activation.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Proteínas Proto-Oncogénicas c-jun / Infarto de la Arteria Cerebral Media / Proteínas Quinasas JNK Activadas por Mitógenos / Caspasa 3 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuroscience Año: 2007 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos / Proteínas Proto-Oncogénicas c-jun / Infarto de la Arteria Cerebral Media / Proteínas Quinasas JNK Activadas por Mitógenos / Caspasa 3 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuroscience Año: 2007 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos